Lithium Citrate Syrup and Trastuzumab and Hyaluronidase
Determining the interaction of Lithium Citrate Syrup and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Citrate Syrup-Trastuzumab Injection (Intravenous)
- Lithium Citrate Syrup-Trastuzumab Intravenous
- Lithium Citrate Syrup-Trastuzumab-anns
- Lithium Citrate Syrup-Trastuzumab-dkst
- Lithium Citrate Syrup-Trastuzumab-dkst Intravenous
- Lithium Citrate Syrup-Trasylol
- Trastuzumab and Hyaluronidase-Lithium Controlled-Release and Extended-Release Tablets
- Trastuzumab and Hyaluronidase-Lithium ER
- Trastuzumab and Hyaluronidase-Lithium Oral Solution
- Trastuzumab and Hyaluronidase-Lithium Salts
- Trastuzumab and Hyaluronidase-Lithium Syrup and Oral Solution
- Trastuzumab and Hyaluronidase-Lithobid